Latest China News

Talga Group has marked a milestone with its first commercial delivery of natural graphite anode outside Asia, progressing key funding discussions and strategic partnerships to support its Vittangi Anode Project.

Actinogen Medical’s pivotal XanaMIA Alzheimer’s trial stays on track for November topline results, buoyed by strong open-label extension enrolment and aligned EMA-FDA regulatory advice. A new antidepressant study publication and fresh patents add momentum, supported by a $16.7 million cash runway to mid-2027.

Firebird Metals has secured a Perth site and placed all major equipment orders for its Australian Demonstration Plant, backed by a A$2 million ARENA grant. Independent testing confirms ultra-high purity manganese sulphate production, reinforcing its technology's potential.

NOVONIX has hit a critical milestone by delivering a synthetic graphite anode sample to Panasonic, supporting a planned production start in late 2027. The company secured A$21.66 million in fresh capital to fund production readiness, while navigating an evolving US trade and policy landscape aimed at boosting domestic battery materials.

Dimerix Limited (ASX: DXB) has inked its fifth regional licensing agreement with Everest Medicines, boosting potential milestone payments to A$1.9 billion and expanded its kidney disease pipeline through the acquisition of DMX-652. The Phase 3 ACTION3 trial for DMX-200 remains statistically robust, with funding secured to advance both clinical programs.

Right Resources’ latest quarter reveals a promising new Reduced Intrusion-Related Gold System and high-grade tungsten discoveries at Tumbarumba, backed by a $2.7 million capital raise.

Xenitra Limited (ASX:XEN) has turned around its cash flow in Q4 FY26, reporting positive operating cash flow of A$0.8 million driven by a leaner cost base and a shift towards higher-margin OTC medicines and blockchain-enabled OPAL tokenised sales.

Australian Silica Quartz Group (ASQ) finalises its acquisition of Australian Kaolin, securing a 47Mt kaolin resource and mining approval for a 250,000 tonne per annum operation. The company progresses kaolin beneficiation in China, explores high purity quartz projects, and advances gold targets at Koolyanobbing, supported by a $1.33m cash position.

PLS Group Limited delivered record FY26 lithium production and sales, boosted revenue 152%, and commenced Ngungaju plant restart, setting the stage for growth with P2000 expansion feasibility underway.

Estrella Resources has delivered a 27,371-tonne manganese stockpile with nearly 5,000 tonnes grading above 49% Mn at Ira Miri and declared a maiden 621Mt JORC Inferred limestone resource at Werumata, underpinning its emerging Timor-Leste portfolio.

RooLife Group (ASX:RLG) is expanding its renewable energy footprint by acquiring a battery storage and microgrid business and raising $1.06 million in a placement to fund growth and project delivery.

Astron Limited is progressing a $220 million senior debt facility for its Donald Rare Earth and Mineral Sands Project, targeting a Final Investment Decision in Q3 2026. The company’s joint venture partner Energy Fuels Inc. is expanding its rare earth supply chain with a $1.9 billion acquisition, while a revised Phase 2 study boosts the project’s combined NPV to $2.3 billion.